235 related articles for article (PubMed ID: 38572959)
1. ABC transporter inhibition by beauvericin partially overcomes drug resistance in
Al Khoury C; Thoumi S; Tokajian S; Sinno A; Nemer G; El Beyrouthy M; Rahy K
Antimicrob Agents Chemother; 2024 May; 68(5):e0136823. PubMed ID: 38572959
[TBL] [Abstract][Full Text] [Related]
2. Sitamaquine overcomes ABC-mediated resistance to miltefosine and antimony in Leishmania.
Pérez-Victoria JM; Bavchvarov BI; Torrecillas IR; Martínez-García M; López-Martín C; Campillo M; Castanys S; Gamarro F
Antimicrob Agents Chemother; 2011 Aug; 55(8):3838-44. PubMed ID: 21646479
[TBL] [Abstract][Full Text] [Related]
3. Alkyl-lysophospholipid resistance in multidrug-resistant Leishmania tropica and chemosensitization by a novel P-glycoprotein-like transporter modulator.
Pérez-Victoria JM; Pérez-Victoria FJ; Parodi-Talice A; Jiménez IA; Ravelo AG; Castanys S; Gamarro F
Antimicrob Agents Chemother; 2001 Sep; 45(9):2468-74. PubMed ID: 11502516
[TBL] [Abstract][Full Text] [Related]
4. Beauvericin potentiates the activity of pesticides by neutralizing the ATP-binding cassette transporters in arthropods.
Al Khoury C; Nemer N; Nemer G
Sci Rep; 2021 May; 11(1):10865. PubMed ID: 34035330
[TBL] [Abstract][Full Text] [Related]
5. Computationally designed synthetic peptides for transporter proteins imparts allostericity in Miltefosine resistant L. major.
Kabra R; Ingale P; Singh S
Biochem J; 2020 May; 477(10):2007-2026. PubMed ID: 32391551
[TBL] [Abstract][Full Text] [Related]
6. Characterization of an ABCG-like transporter from the protozoan parasite Leishmania with a role in drug resistance and transbilayer lipid movement.
Castanys-Muñoz E; Pérez-Victoria JM; Gamarro F; Castanys S
Antimicrob Agents Chemother; 2008 Oct; 52(10):3573-9. PubMed ID: 18644961
[TBL] [Abstract][Full Text] [Related]
7. Miltefosine-induced apoptotic cell death on Leishmania major and L. tropica strains.
Khademvatan S; Gharavi MJ; Rahim F; Saki J
Korean J Parasitol; 2011 Mar; 49(1):17-23. PubMed ID: 21461264
[TBL] [Abstract][Full Text] [Related]
8. The potential therapeutic role of PTR1 gene in non-healing anthroponotic cutaneous leishmaniasis due to Leishmania tropica.
Sezavar M; Sharifi I; Ghasemi Nejad Almani P; Kazemi B; Davoudi N; Salari S; Salarkia E; Khosravi A; Bamorovat M
J Clin Lab Anal; 2021 Mar; 35(3):e23670. PubMed ID: 33283321
[TBL] [Abstract][Full Text] [Related]
9. The LABCG2 Transporter from the Protozoan Parasite Leishmania Is Involved in Antimony Resistance.
Perea A; Manzano JI; Castanys S; Gamarro F
Antimicrob Agents Chemother; 2016 Jun; 60(6):3489-96. PubMed ID: 27021316
[TBL] [Abstract][Full Text] [Related]
10. Role of the ABC transporter PRP1 (ABCC7) in pentamidine resistance in Leishmania amastigotes.
Coelho AC; Messier N; Ouellette M; Cotrim PC
Antimicrob Agents Chemother; 2007 Aug; 51(8):3030-2. PubMed ID: 17452480
[TBL] [Abstract][Full Text] [Related]
11. Identification of antimony resistance markers in Leishmania tropica field isolates through a cDNA-AFLP approach.
Kazemi-Rad E; Mohebali M; Khadem-Erfan MB; Saffari M; Raoofian R; Hajjaran H; Hadighi R; Khamesipour A; Rezaie S; Abedkhojasteh H; Heidari M
Exp Parasitol; 2013 Oct; 135(2):344-9. PubMed ID: 23928349
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo miltefosine susceptibility of a Leishmania amazonensis isolate from a patient with diffuse cutaneous leishmaniasis.
Coelho AC; Trinconi CT; Costa CH; Uliana SR
PLoS Negl Trop Dis; 2014 Jul; 8(7):e2999. PubMed ID: 25033218
[TBL] [Abstract][Full Text] [Related]
13. Gene expression analysis of antimony resistance in Leishmania tropica using quantitative real-time PCR focused on genes involved in trypanothione metabolism and drug transport.
Mohebali M; Kazemirad E; Hajjaran H; Kazemirad E; Oshaghi MA; Raoofian R; Teimouri A
Arch Dermatol Res; 2019 Jan; 311(1):9-17. PubMed ID: 30390113
[TBL] [Abstract][Full Text] [Related]
14. Protein kinase C effectors bind to multidrug ABC transporters and inhibit their activity.
Conseil G; Perez-Victoria JM; Jault JM; Gamarro F; Goffeau A; Hofmann J; Di Pietro A
Biochemistry; 2001 Feb; 40(8):2564-71. PubMed ID: 11327879
[TBL] [Abstract][Full Text] [Related]
15. Structure based investigation on the binding interaction of transport proteins in leishmaniasis: insights from molecular simulation.
Singh S; Mandlik V
Mol Biosyst; 2015 May; 11(5):1251-9. PubMed ID: 25761976
[TBL] [Abstract][Full Text] [Related]
16. Glucantime-resistant Leishmania tropica isolated from Iranian patients with cutaneous leishmaniasis are sensitive to alternative antileishmania drugs.
Hadighi R; Boucher P; Khamesipour A; Meamar AR; Roy G; Ouellette M; Mohebali M
Parasitol Res; 2007 Oct; 101(5):1319-22. PubMed ID: 17610079
[TBL] [Abstract][Full Text] [Related]
17. Leishmaniasis: efflux pumps and chemoresistance.
Leandro C; Campino L
Int J Antimicrob Agents; 2003 Sep; 22(3):352-7. PubMed ID: 13678842
[TBL] [Abstract][Full Text] [Related]
18. Treatment failure and miltefosine susceptibility in dermal leishmaniasis caused by Leishmania subgenus Viannia species.
Obonaga R; Fernández OL; Valderrama L; Rubiano LC; Castro Mdel M; Barrera MC; Gomez MA; Gore Saravia N
Antimicrob Agents Chemother; 2014; 58(1):144-52. PubMed ID: 24145529
[TBL] [Abstract][Full Text] [Related]
19. In-vitro sensitivity of Pakistani Leishmania tropica field isolate against buparvaquone in comparison to standard anti-leishmanial drugs.
Jamal Q; Khan NH; Wahid S; Awan MM; Sutherland C; Shah A
Exp Parasitol; 2015 Jul; 154():93-7. PubMed ID: 25911243
[TBL] [Abstract][Full Text] [Related]
20. Insights into the trypanothione system in antimony-resistant and sensitive Leishmania tropica clinical isolates.
Valashani HT; Ahmadpour M; Naddaf SR; Mohebali M; Hajjaran H; Latifi A; Salimi M; Farahmand M; Naeimi S; Raissi V; Kazemirad E
Acta Trop; 2024 Jun; 254():107190. PubMed ID: 38508372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
